FDAFDA · Food and drugs·Recall number D-0559-2024
Cefixime for Oral Suspension USP 200 mg/5 mL (50 mL Pack size), Powder for oral suspension, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore Maryland, Manufactured by: Lupin Limited, Mandideep, India NDC 68180-407-03
Published June 26, 2024 · Recall initiated: May 30, 2024
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Content Uniformity Specifications
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- CEFIXIME
- Manufacturer
- Lupin Pharmaceuticals Inc.
- Distributor
- Nationwide in the US
- UPC
- 0368180423089
- Lot
- Lot F201519, Expiry: November 2024
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.